You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

High Risk Malignancies

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hypomethylating Agent, Venetoclax, Myeloid Malignancy Trial in Shanghai (Venetoclax, Azacitidine or decitabine)

Recruiting
  • Hypomethylating Agent
  • +2 more
  • Shanghai, Shanghai, China
    Shanghai Jiao Tong University School of Medicine Affilated Shang
May 2, 2023

CNS Tumor, Solid Tumor Trial in Worldwide (Nivolumab and Entinostat)

Recruiting
  • CNS Tumor
  • Solid Tumor
  • Nivolumab and Entinostat
  • Randwick, New South Wales, Australia
  • +13 more
Nov 8, 2022

Hematologic Tumors Trial run by the NCI (donor lymphocyte infusion, Cyclophosphamide, Busulfan)

Suspended
  • Hematologic Neoplasms
  • donor lymphocyte infusion
  • +5 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Nov 30, 2022

Leukemia, Myeloid, Acute, MDS, Hematopoietic Stem Cell Transplantation Trial in Shanghai (Venetoclax plus RIC)

Not yet recruiting
  • Leukemia, Myeloid, Acute
  • +3 more
  • Venetoclax plus RIC
  • Shanghai, Shanghai, China
    Shanghai General Hospital
Oct 12, 2022

l, Laboratory and Epidemiologic Characterization of Individuals

Completed
  • Familial Ovarian Cancer
  • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Dec 31, 2022

    Acute Myeloid Leukemia, B-cell Acute Lymphoblastic Leukemia, High-risk Myelodysplastic Syndrome Trial (VIP943)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • +2 more
    • (no location specified)
    Sep 5, 2023

    Allogenic Stem Cell Transplantation Trial (SAR445419)

    Not yet recruiting
    • Allogenic Stem Cell Transplantation
    • (no location specified)
    Feb 13, 2023

    MDS, de Novo, MDS, Secondary, MDS, Previously Treated Trial in Boston (Venetoclax, Azacitidine, Cytarabine)

    Recruiting
    • Myelodysplastic Syndromes, de Novo
    • +10 more
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    Jan 23, 2023

    Cell-free DNA in Hereditary And High-Risk Malignancies

    Recruiting
    • Hereditary Cancer Syndrome
    • Next generation sequencing (NGS)
    • Vancouver, British Columbia, Canada
    • +6 more
    Feb 14, 2022

    Myeloid Malignancies, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Houston (Cyclophosphamide, Mesna, Filgrastim)

    Recruiting
    • Myeloid Malignancies
    • +3 more
    • Houston, Texas
      M D Anderson Caner Center
    Nov 17, 2022

    High Risk Myeloid Malignancies, Cord Blood Transplant Trial in New York (ECT-001-CB (UM171-Expanded Cord Blood Transplant))

    Recruiting
    • High Risk Myeloid Malignancies
    • Cord Blood Transplant
    • ECT-001-CB (UM171-Expanded Cord Blood Transplant)
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Jan 12, 2022

    Leukemia, Myelodysplastic Syndrome, Lymphoma Trial in New York (CliniMACS Fractionation system (Arm A), CliniMACS Fractionation

    Completed
    Has Results
    • Leukemia
    • +2 more
    • CliniMACS Fractionation system (Arm A)
    • +2 more
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Jul 12, 2022

    Hematologic Malignancies, Inborn Errors of Metabolism Disorders, Immune Deficiencies Trial in Durham (CliniMACS CD34 Reagent

    Available
    • Hematologic Malignancies
    • +2 more
    • CliniMACS CD34 Reagent System
    • Durham, North Carolina
      Duke University Medical Center
    Nov 12, 2021

    Relapsed and/or Refractory Acute Myeloid Leukemia, High Risk Hematologic Malignancies Trial in Langfang (anti-CD33 CAR T cells)

    Not yet recruiting
    • Relapsed and/or Refractory Acute Myeloid Leukemia
    • High Risk Hematologic Malignancies
    • anti-CD33 CAR T cells
    • Langfang, Hebei, China
      Hebei Yanda Lu Daopei Hospital
    Jun 30, 2022

    Hematologic Malignancies, Relapse, GVHD Trial in Ann Arbor (Carfilzomib, Tacrolimus)

    Completed
    Has Results
    • Hematologic Malignancies
    • +2 more
    • Ann Arbor, Michigan
      University of Michigan Hospital
    Dec 3, 2021

    Relapsed/Refractory, High Risk Hematologic Malignancies, T-ALL/Lymphoma Trial in Langfang (CD7CAR T cells)

    Recruiting
    • Relapsed/Refractory, High Risk Hematologic Malignancies
    • T-ALL/Lymphoma
    • CD7CAR T cells
    • Langfang, Hebei, China
      Hebei Yanda Lu Daopei Hospital
    Jun 30, 2022

    High-risk MDS, Acute Myelogenous Leukemia, Systemic Mastocytosis Trial in Minneapolis, Madison (GTB-3550 TriKE® Phase I,

    Terminated
    • High-risk Myelodysplastic Syndromes
    • +3 more
    • GTB-3550 TriKE® Phase I
    • GTB-3550 TriKE® Phase II
    • Minneapolis, Minnesota
    • +1 more
    Mar 21, 2022

    Leukemia, Lymphoma, Lymphoma, B-Cell Trial in New York (CAR T-Cell Infusion)

    Withdrawn
    • Leukemia
    • +2 more
    • CAR T-Cell Infusion
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Mar 4, 2022

    Leukemia, Myeloid, Acute Trial (GSK3745417)

    Not yet recruiting
    • Leukemia, Myeloid, Acute
    • (no location specified)
    Jun 15, 2022

    Relapsed/Refractory Hematopoietic Malignancies, Acute Myeloid Leukemia and MDS Trial in Washington, Baltimore (Tumor associated

    Recruiting
    • Relapsed/Refractory Hematopoietic Malignancies, Acute Myeloid Leukemia and MDS
    • Tumor associated antigen lymphocytes (TAA-T)
    • Washington, District of Columbia
    • +1 more
    Jul 15, 2021

    Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Hodgkin Lymphoma Trial in Madison (TCRaß+/CD19+ depleted Haploidentical

    Recruiting
    • Acute Myeloid Leukemia
    • +10 more
    • Madison, Wisconsin
      University of Wisconsin Carbone Cancer Center
    Mar 1, 2022

    Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Erythroid Leukemia, Acute Megakaryoblastic Leukemia

    Completed
    • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    • +14 more
    • Aldesleukin
    • +7 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 31, 2022

    Myeloid Malignancy, MDS, Myelofibrosis Trial in Boston (Navitoclax, Venetoclax, Decitabine)

    Recruiting
    • Myeloid Malignancy
    • +4 more
    • Boston, Massachusetts
    • +2 more
    Jul 21, 2022

    Hematologic Tumors Trial in Milan (Cyclophosphamide, Hematopoietic Stem Cell Transplantation,)

    Recruiting
    • Hematologic Neoplasms
    • Milan, Italy
      European Institute of Oncology
    Sep 24, 2021

    Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With

    Active, not recruiting
    • Adult Acute Lymphoblastic Leukemia in Remission
    • +14 more
    • radiation therapy
    • +8 more
    • Columbus, Ohio
      Arthur G. James Cancer Hospital and Solove Research Institute at
    Oct 7, 2022